Table 3 Associations between the IGF1 rs5742714 polymorphism and RCC patients’ survival.
IGF1 rs5742714 | Patients (N = 311) | Deaths (N = 33) | 5-yr survival* (%) | Log-Rank P | HR (95% CI)† |
---|---|---|---|---|---|
Codominant model | |||||
GG | 205 | 27 | 77.1% | 1.00 (reference) | |
GC | 93 | 5 | 88.9% | 0.031 | 0.36 (0.14–0.94) |
CC | 13 | 1 | 85.7% | 0.440 | 0.47 (0.06–3.51) |
Additive model | 0.046 | 0.45 (0.21–0.99) | |||
Dominant model | |||||
GG | 205 | 27 | 77.1% | 0.025 | 1.00 (reference) |
GC/CC | 106 | 6 | 88.0% | 0.36 (0.14–0.93) |